BeStock  
股票 › CAR-T疗法 › JNJ

强生 JNJ

美股市值排名 #24CAR-T疗法传染病
$276.22 +$3.90 (+1.43%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $276.00 -0.08%
开盘$267.56
昨收$272.32
当日区间$265.55 – $276.41
成交量8.86M
市值$664.95B
市盈率(TTM)42.0
股息率1.91%

基本面

最新报告季度:Q3, ended Sep 2026

营收$25.40B+5.9% YoY
营业利润$6.37B-10.3% YoY
净利润$210.00M-95.9% YoY
摊薄每股收益$0.09-95.9% YoY
自由现金流$5.36B-32.9% YoY
经营现金流$7.72B

营收,近8个季度

$21.9BMar '25$23.7BJun '25$24.0BSep '25$24.6BDec '25$24.1BMar '26$25.3BJun '26$25.4BSep '26$25.4BSep '26

净利润,近8个季度

$11.0BMar '25$5.5BJun '25$5.2BSep '25$5.1BDec '25$5.2BMar '26$5.5BJun '26$210.0MSep '26$210.0MSep '26

各季度摊薄每股收益

4.54Mar '252.29Jun '252.12Sep '252.10Dec '252.14Mar '262.27Jun '260.09Sep '260.09Sep '26

各季度自由现金流

$4.8BDec '24$3.4BMar '25$2.5BJun '25$8.0BSep '25$5.5BDec '25$1.5BMar '26$7.3BJun '26$5.4BSep '26

年度营收

$82.6BFY20$78.7BFY21$80.0BFY22$85.2BFY23$88.8BFY24$94.2BFY25

盈利能力与资产负债表

毛利率67.6%
营业利润率25.7%
净利率16.2%
负债/资产比率58.7%
现金及投资$17.23B
总负债$44.65B
净现金(净负债)-$27.42B

营收构成

2026/Q3 季度

按业务线

  • Innovative Medicine$16.76B 66.0%
  • MedTech$8.64B 34.0%

利润表

项目 2026 Q3 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL
报告营业总收入 $25.40B $25.40B $25.31B $24.06B $94.19B
营业总收入 $25.40B $25.40B $25.31B $24.06B $94.19B
营业成本 $8.10B $8.10B $8.05B $8.11B $30.26B
毛利润 $17.30B $17.30B $17.26B $15.96B $63.94B
营业费用 $10.94B $10.94B $10.09B $9.56B $38.34B
销售及管理费用 $6.29B $6.29B $6.43B $6.03B $23.68B
研发费用 $4.65B $4.65B $3.65B $3.53B $14.67B
营业利润 $6.37B $6.37B $7.17B $6.40B $25.60B
非经营性利息净收入(支出) -$31.00M -$31.00M -$62.00M -$43.00M $85.00M
其他财务成本合计 $31.00M – – – –
其他收入(支出) -$6.30B -$6.32B -$365.00M -$362.00M $6.89B
特殊收益(费用) -$520.00M -$6.62B -$34.00M -$468.00M $5.49B
-减:重组及并购费用 $181.00M $181.00M $34.00M $132.00M $428.00M
-减:资本性资产减值 $339.00M – – – $81.00M
其他非经营性收入(支出) -$5.78B $300.00M -$331.00M $106.00M $1.00B
税前利润 $34.00M $34.00M $6.75B $5.99B $32.58B
税费 -$176.00M -$176.00M $1.21B $755.00M $5.78B
净利润 $210.00M $210.00M $5.53B $5.24B $26.80B
持续经营利润 $210.00M $210.00M $5.53B $5.24B $26.80B
归属母公司净利润 $210.00M $210.00M $5.53B $5.24B $26.80B
归属普通股股东净利润 $210.00M $210.00M $5.53B $5.24B $26.80B
基本每股收益 $0.09 $0.09 $2.30 $2.17 $11.13
摊薄每股收益 $0.09 $0.09 $2.27 $2.14 $11.03
每股股息 $1.34 $1.34 $1.34 $1.30 $5.14
非经营性利息收入 – $186.00M $219.00M $229.00M $1.06B
非经营性利息支出 – $217.00M $281.00M $272.00M $971.00M
-减:其他特殊支出 – $6.10B – $300.00M -$6.00B
-减:核销 – $339.00M – $36.00M –
证券出售收益 – – – – $400.00M
终止经营净利润 – – – – $0.00

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $197.43B $201.06B $200.89B $199.21B $199.21B
流动资产合计 $56.35B $59.77B $59.17B $55.62B $55.62B
现金及现金等价物与短期投资 $17.23B $20.76B $22.05B $20.10B $20.10B
-现金及现金等价物 $16.91B $20.42B $21.69B $19.71B $19.71B
-短期投资 $318.00M $336.00M $363.00M $393.00M $393.00M
应收款 $18.99B $19.05B $22.54B $21.33B $21.33B
-应收账款 $18.99B $19.05B $17.72B $17.18B $17.18B
存货 $15.38B $15.14B $14.58B $14.19B $14.19B
其他流动资产 $4.76B $4.83B – – –
非流动资产合计 $141.07B $141.29B $141.72B $143.59B $143.59B
固定资产净值 $24.10B $23.58B $23.27B $23.17B $23.17B
-固定资产原值 $55.47B $55.52B $54.70B $54.36B $54.36B
-累计折旧 -$31.37B -$31.94B -$31.43B -$31.20B -$31.20B
商誉及其他无形资产 $95.13B $96.71B $97.62B $99.18B $99.18B
-商誉 $48.47B $48.48B $48.56B $48.77B $48.77B
-其他无形资产 $46.65B $48.23B $49.06B $50.40B $50.40B
一年以上递延资产 $6.75B $6.73B $6.73B $6.87B $6.87B
其他非流动资产 $15.10B $14.27B $14.11B $14.37B $14.37B
负债合计 $115.90B $116.09B $119.71B $117.67B $117.67B
流动负债合计 $55.46B $54.90B $57.72B $54.13B $54.13B
应付款 $11.29B $10.27B $11.55B $13.38B $13.38B
-应付账款 $9.32B $9.22B $10.46B $11.99B $11.99B
-应付税款合计 $1.98B $1.05B $1.09B $1.39B $1.39B
一年内应计费用 $31.19B $29.45B $25.80B $27.72B $27.72B
短期债务及融资租赁负债 $8.85B $11.69B $17.46B $8.50B $8.50B
-一年内到期债务 $8.85B $11.69B $17.46B $8.50B $8.50B
非流动负债合计 $60.44B $61.20B $61.99B $63.54B $63.54B
长期应付账款及其他应付款 $497.00M $485.00M $486.00M $486.00M $486.00M
长期债务及融资租赁负债 $35.80B $37.34B $37.53B $39.44B $39.44B
-长期债务 $35.80B $37.34B $37.53B $39.44B $39.44B
一年以上递延负债 $4.84B $6.61B $7.01B $6.79B $6.79B
员工福利 $6.56B $6.66B $6.76B $6.96B $6.96B
其他非流动负债 $12.75B $10.10B $10.21B $9.87B $9.87B
股东权益合计 $81.53B $84.97B $81.19B $81.54B $81.54B
股东权益 $81.53B $84.97B $81.19B $81.54B $81.54B
股本 $3.12B $3.12B $3.12B $3.12B $3.12B
-普通股 $3.12B $3.12B $3.12B $3.12B $3.12B
资本公积 $168.36B $171.67B $169.16B $168.98B $168.98B
减:库存股 $76.18B $75.86B $76.26B $75.62B $75.62B
不影响留存收益的损益 -$13.77B -$13.95B -$14.83B -$14.93B -$14.93B
-其他应收款 – – $4.82B $4.15B $4.15B
-优先股 – – – $0.00 $0.00

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $7.72B $8.62B $2.51B $24.53B $7.31B
持续经营经营活动现金流净额 $7.72B $8.62B $2.51B $24.53B $7.31B
持续经营净利润 $210.00M $5.53B $5.24B $26.80B $5.12B
持续经营损益 $16.00M -$55.00M $12.00M -$263.00M -$132.00M
折旧、折耗与摊销 $2.12B $1.96B $2.00B $7.50B $2.01B
递延税款 -$1.79B -$479.00M $159.00M $1.54B -$3.68B
其他非现金项目 $962.00M $0.00 $2.00M $109.00M $0.00
营运资金变动 $5.25B $1.02B -$5.23B -$12.72B $3.60B
-应收款变动 $188.00M -$1.35B -$595.00M -$1.78B $391.00M
-存货变动 -$150.00M -$571.00M -$431.00M -$1.45B -$46.00M
-应付账款及应计费用变动 $2.41B $2.96B -$3.92B $2.38B $1.27B
-其他流动资产变动 $122.00M $950.00M $349.00M -$6.17B $1.49B
-其他流动负债变动 $2.69B -$972.00M -$629.00M -$5.70B $499.00M
投资活动现金流净额 -$2.71B -$1.11B -$1.04B -$23.59B -$4.49B
持续经营投资活动现金流净额 -$2.71B -$1.11B -$1.04B -$23.59B -$4.49B
固定资产购置及出售净额 -$1.36B -$1.32B -$1.05B -$4.83B -$1.84B
无形资产购置及出售净额 -$995.00M $0.00 $0.00 -$385.00M $0.00
业务购买及出售净额 -$89.00M – – -$17.54B -$3.08B
投资购置及出售净额 -$253.00M $519.00M $65.00M $741.00M $2.31B
其他投资变动净额 -$10.00M -$45.00M -$56.00M -$1.57B -$1.88B
筹资活动现金流 -$8.53B -$8.78B $530.00M -$5.54B -$1.37B
持续经营筹资活动现金流净额 -$8.53B -$8.78B $530.00M -$5.54B -$1.37B
债务发行及偿还净额 -$4.36B -$5.75B $7.21B $9.64B $2.11B
普通股发行净额 -$1.71B -$221.00M -$4.03B -$5.95B -$1.92B
已付现金股利 -$3.23B -$3.23B -$3.13B -$12.38B -$3.13B
股票期权行使所得 $743.00M $359.00M $1.17B $3.42B $1.59B
其他筹资费用净额 $18.00M $60.00M -$697.00M -$260.00M -$6.00M
期末现金余额 $16.91B $20.42B $21.69B $19.71B $19.71B
现金净变动 -$3.52B -$1.27B $2.00B -$4.60B $1.46B
期初现金余额 $20.42B $21.69B $19.71B $24.11B $18.23B
汇率变动影响 $10.00M $5.00M -$25.00M $201.00M $23.00M
自由现金流 $5.36B $7.30B $1.47B $19.31B $5.47B

讨论区

暂无评论——快来第一个聊聊 JNJ。

登录后参与讨论。

Scroll to Top